HLD-0915

· Halda Therapeutics OpCo, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HLD-0915, covering 2025-10-16 to 2025-10-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study of HLD-0915 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) [Phase 1, Phase 2]